The TyG-BMI is an extension of the simpler triglyceride glucose index, a surrogate measure of insulin resistance that has gained popularity because it requires only fasting triglycerides, fasting glucose and, in this variant, body mass index. Insulin resistance, the reduced ability of cells to respond to the hormone insulin, is usually discussed in the context of type 2 diabetes and cardiovascular disease, but it also intersects with psychiatric research. Directly measuring insulin resistance with a hyperinsulinaemic glucose clamp, the laboratory gold standard, is expensive and impractical in population studies, so indices like TyG and TyG-BMI have become widely used proxies. The TyG-BMI multiplies the logarithm of the product of fasting triglycerides and glucose by BMI, producing a single number that captures both circulating lipid-glucose dynamics and overall adiposity.

The research team, led by Chunyue Guo and Bin Yang of Tianjin University’s Central Hospital together with colleagues at Tianjin institutions, analyzed data from 8,397 participants aged 45 and older. Of these, 3,902 were men and 4,495 were women, and the mean age was 59.25 years. Depressive symptoms were assessed with the 10-item Center for Epidemiological Studies Depression Scale, a brief screening instrument widely used in epidemiological surveys. Nearly three in ten participants, 28.56 percent, screened positive for depressive symptoms, a prevalence that underscores the scale of the mental health burden in this age group in China.

To probe the relationship, the investigators used two complementary statistical approaches. Multivariable logistic regression allowed them to estimate the odds of depressive symptoms across quartiles of TyG-BMI while adjusting for potential confounders. Restricted cubic spline analysis, a flexible modeling technique, let them map the shape of the association across the full range of the marker rather than forcing it into arbitrary categories. The spline results were notable for their simplicity: the relationship was linear, with a nonlinearity test yielding a p-value of 0.3274, meaning the data gave no evidence that the association curved, plateaued or reversed direction anywhere along the TyG-BMI spectrum.

The quartile analysis told a consistent story. Compared with participants in the lowest quartile of TyG-BMI, those in the second quartile had 16 percent lower odds of depressive symptoms, an adjusted odds ratio of 0.841. The third quartile showed an odds ratio of 0.726, and the highest quartile an odds ratio of 0.706, corresponding to roughly 27 to 29 percent lower odds. When TyG-BMI was treated as a continuous variable, each single-unit increase was associated with 0.4 percent lower odds of depressive symptoms, each 10-unit increase with 3.9 percent lower odds, and each one-standard-deviation increase with a 14.4 percent reduction. These effect sizes are modest at the individual level but meaningful across an entire aging population.

Importantly, the inverse association held up across prespecified subgroups. The researchers tested for interactions by sex, age and other strata and found none that reached statistical significance, with all interaction p-values above 0.05. Sensitivity analyses were conducted to check the robustness of the findings, and the overall pattern remained stable. That kind of consistency matters in observational epidemiology, where a signal that appears in one subgroup but not another often hints at confounding or chance rather than a genuine biological relationship.

What could explain a link between higher insulin resistance and fewer depressive symptoms? The authors are careful not to overinterpret, but several biological narratives are plausible. Adipose tissue and insulin signaling interact with brain pathways involving serotonin, dopamine and brain-derived neurotrophic factor, and some researchers have proposed that in certain contexts, greater energy reserves or more efficient glucose metabolism could buffer the brain against stress-related damage. Conversely, depression itself can suppress appetite and reduce body weight, meaning that some people with depressive symptoms may simply have lower TyG-BMI values because of their illness rather than the reverse. Reverse causation of this kind is a persistent hazard in cross-sectional research, where exposure and outcome are measured at the same moment in time.

There are also demographic and behavioral confounders to consider. Body mass index, diet, physical activity, chronic disease burden and socioeconomic position all shape both metabolic health and mental health, and even careful statistical adjustment cannot fully remove their influence. The study’s cross-sectional design means it captures a snapshot rather than a trajectory; it can establish that higher TyG-BMI and lower depressive symptom prevalence co-occur, but not which, if either, drives the other. The authors explicitly frame their conclusions as exploratory and call for prospective cohort studies that follow participants over time, measuring TyG-BMI before the onset of depressive symptoms, to test whether the association survives temporal ordering.

Despite these caveats, the findings add to a growing and sometimes contradictory literature on metabolic markers and late-life depression. Previous studies using the simpler TyG index and related insulin resistance surrogates in other populations, including analyses of the United States National Health and Nutrition Examination Survey, have reported associations in varying directions, reflecting differences in population age structure, adiposity distributions, dietary patterns and how depression was measured. The Chinese context is particularly important because the country is aging rapidly, and the CHARLS cohort offers nationally representative sampling of community-dwelling adults, with ethics approval from Peking University’s Biomedical Ethics Committee and written informed consent from all participants.

For clinicians and public health researchers, the practical takeaway is not that raising insulin resistance would protect mental health, a claim the data cannot support. Rather, the study highlights TyG-BMI as a cheap, calculable marker that may help stratify risk or illuminate metabolic pathways relevant to mood disorders in aging populations. Fasting triglycerides and glucose are measured routinely in blood panels, and BMI requires only height and weight, so the index could be computed at virtually no additional cost in existing cohorts and clinical records worldwide. If prospective studies confirm and clarify the relationship, the TyG-BMI could become a useful thread in the broader effort to untangle how metabolic and mental health intertwine in the second half of life.

Subject of Research: Association between the triglyceride glucose-body mass index, an insulin resistance surrogate, and depressive symptoms in middle-aged and older Chinese adults

Article Title: Associations between triglyceride glucose-body mass index and depressive symptoms among middle-aged and older adults

Article References: Guo, C., Song, C., Zhao, J., & Yang, B. (2026). Associations between triglyceride glucose-body mass index and depressive symptoms among middle-aged and older adults. BMC Psychiatry. https://doi.org/10.1186/s12888-026-08651-4

Image Credits: AI Generated

DOI: 10.1186/s12888-026-08651-4

Keywords: TyG-BMI, insulin resistance, depressive symptoms, CHARLS, CES-D-10, middle-aged adults, older adults, cross-sectional study, logistic regression, restricted cubic spline, BMC Psychiatry, China

The research team, led by Shu-Fen Cheng, Yun-Ying Ding, and corresponding author Hua-Dong Hong, drew their evidence from the China Health and Retirement Longitudinal Study, known as CHARLS, a nationally representative survey that follows thousands of Chinese households over time. From the 2018 wave, the investigators identified 1,269 patients with gastrointestinal diseases who were at least 45 years old. Depression was defined using the ten-item Center for Epidemiologic Studies Depression Scale, or CES-D-10, a widely used brief questionnaire in which a score of 10 or more signals clinically relevant depressive symptoms. By this threshold, nearly half of the study population — a baseline prevalence of 49.2 percent — screened positive, a figure that underscores just how intertwined gut disease and mood disturbance become in later life.

What makes the study methodologically interesting is the way the team chose which variables to keep. Rather than dumping every available survey item into a model and hoping for the best, they used a hybrid feature-selection strategy combining Boruta, an algorithm built around randomized decision forests that tests each variable against shuffled copies of itself, with LASSO regression, a technique that shrinks the coefficients of weak predictors all the way to zero. The result was a parsimonious set of six core predictors: self-rated health status, trouble with body pain, gender, difficulty with instrumental activities of daily living such as shopping and managing medications, sleep duration, and limitations in basic activities of daily living like dressing and bathing. Six variables is a number a nurse could collect in a couple of minutes.

Then came the contest. The researchers pitted six machine learning algorithms against one another — logistic regression, K-nearest neighbors, support vector machine, random forest, gradient boosting machine, and extreme gradient boosting — tuning each model’s hyperparameters through ten-fold cross-validation, a procedure that repeatedly splits the data so that every case gets a turn in the test set. The verdict was, on its face, a small embarrassment for the fancy algorithms: plain, old-fashioned logistic regression, a statistical method older than most of the people studying it, showed the best generalizability on the validation cohort. Its area under the receiver operating characteristic curve, the standard measure of discrimination between those with and without the condition, reached 0.697, with a 95 percent confidence interval of 0.644 to 0.748.

Those numbers describe a model of moderate, not spectacular, power, and the authors are candid about that. The logistic regression model achieved an accuracy of 0.651, a sensitivity of 0.722, a specificity of 0.583, and an F1-score of 0.670. In practical terms, the tool catches roughly seven in ten people who are depressed, while correctly clearing a bit more than half of those who are not. For a screening instrument — as opposed to a diagnostic test — that trade-off is defensible, because the cost of a false alarm is merely a fuller clinical evaluation, whereas the cost of a missed case can be months or years of untreated illness. Notably, the area under the precision-recall curve, 0.671, exceeded the baseline prevalence of 0.492, indicating the model adds genuine information beyond simply guessing from the base rate.

Discrimination is only half the story, however. A screening model also needs to produce probabilities that mean what they say. The team assessed calibration using the Brier score, which came in at 0.225, and the Hosmer-Lemeshow test, which returned a p-value of 0.614 — a result that, unusually, is good news, since a high p-value here indicates no statistically significant departure between predicted and observed risk. Decision curve analysis, a technique that quantifies the net clinical benefit of acting on a model’s predictions across a range of risk thresholds, showed positive net benefit across threshold probabilities from 20 to 70 percent. In other words, across most of the range where a clinician might plausibly decide to intervene, using the model beats the two crude alternatives of screening everyone or screening no one.

Perhaps the most visually compelling contribution is the study’s use of SHAP, or SHapley Additive exPlanations, a framework borrowed from cooperative game theory that assigns each feature a fair share of credit for every individual prediction. Rather than treating the model as a black box, SHAP lets researchers and clinicians see exactly how much each variable pushes a given patient’s risk up or down. In this study, SHAP ranked the six predictors by contribution in descending order: health status first, then trouble with body pain, gender, instrumental activities of daily living, sleep time, and activities of daily living. The ordering tells a coherent clinical story — how patients feel overall, and how much pain interferes with their lives, matters more for depression risk than demographic or functional details alone.

The final product is a nomogram, a graphical scoring device that converts each of the six variables into points on a scale, sums them, and translates the total into an estimated probability of depressive symptoms. Nomograms have a long pedigree in medicine, particularly in oncology, precisely because they demand nothing more exotic than a pencil and a printed chart. In settings without reliable internet access or electronic health record integration — which describes a great many clinics where older gastrointestinal patients actually receive care — that simplicity is not a limitation but the entire point. The authors position the tool as a supplementary screening aid for the concurrent identification of depressive symptoms, enabling timely integrated care rather than replacing formal psychiatric assessment.

The study’s limitations deserve honest airing, and the authors supply them. This was a cross-sectional analysis, meaning it captures a single snapshot in time and cannot establish that the measured factors cause depression, only that they travel with it. The validation was internal, performed through resampling within the same dataset rather than on an independent external cohort, and the authors state plainly that external validation is urgently needed before the tool can be recommended broadly. The CHARLS sample, while nationally representative of China, may not generalize to other populations, and self-reported gastrointestinal disease and survey-based measures carry their own measurement error. An AUC just under 0.70 leaves meaningful room for improvement, and no screening chart should ever override a clinician’s judgment or a patient’s own account of their suffering.

Still, the study’s broader message resonates well beyond its specific numbers. At a moment when machine learning is often sold as a substitute for clinical reasoning, this work demonstrates a humbler and arguably more useful paradigm: use the sophisticated algorithms to interrogate the data, then deploy the simplest model that does the job, wrapped in transparency tools that let clinicians see why it predicts what it predicts. For the millions of middle-aged and older adults whose gut ailments and low moods feed each other in silence, a six-question chart that takes minutes to complete could be the difference between depression noticed early and depression discovered late. The research was supported by the Suzhou Science and Technology Development Program and the Suzhou Medical Association, and the underlying CHARLS data were approved by the Ethical Review Committee of Peking University, with all participants providing informed consent. The article is published open access, making the full methods and findings freely available to clinicians and researchers worldwide.

Subject of Research: Depression risk screening in middle-aged and older patients with gastrointestinal diseases using a logistic-regression nomogram

Article Title: A parsimonious logistic-regression nomogram for depression risk screening in middle-aged and older patients with gastrointestinal diseases: a cross-sectional CHARLS study with ML-Style comparison and SHAP visualization

Article References: Cheng, S.-F., Ding, Y.-Y., & Hong, H.-D. (2026). A parsimonious logistic-regression nomogram for depression risk screening in middle-aged and older patients with gastrointestinal diseases: a cross-sectional CHARLS study with ML-Style comparison and SHAP visualization. BMC Psychiatry. https://doi.org/10.1186/s12888-026-08731-5

Image Credits: AI Generated

DOI: 10.1186/s12888-026-08731-5

Keywords: depression, gastrointestinal diseases, CHARLS, logistic regression, nomogram, SHAP, machine learning, screening, CES-D-10, older adults, risk prediction, BMC Psychiatry

The study tackles a question that has long frustrated researchers in social neuroscience and geriatric psychiatry: are the objective and subjective components of social disconnectedness equally harmful, or do they act through different mechanisms and carry different weights of risk? Social isolation refers to a measurable state—few social contacts, infrequent participation in activities, limited networks—while loneliness is a self-perceived gap between the social connection a person wants and the connection they actually have. The two often overlap, but they are far from identical. Someone can be embedded in a large family and still feel profoundly lonely, while another person living alone may feel content and connected. Disentangling these constructs longitudinally has been a persistent methodological challenge, because most prior studies measured disconnection at a single point in time or failed to separate the two dimensions statistically.

To address this, the researchers exploited the seven-year structure of CHARLS, a nationally representative longitudinal survey of middle-aged and older Chinese adults conducted with ethical approval from Peking University and informed consent from all participants. The analytic sample comprised 2,780 adults aged 45 or above at baseline. Depressive symptoms were measured at each wave using the Center for Epidemiologic Studies Depression scale, a ten-item instrument widely validated in population surveys, while cognitive function was assessed and expressed as a standardized Z-score, allowing the team to model changes over time on a common scale. Linear mixed-effects models—the workhorse of longitudinal analysis—were used to estimate individual trajectories of depressive symptoms and cognition, testing whether baseline social isolation or loneliness altered the slope of those trajectories over the seven-year window.

The results on trajectories were striking. Participants with high baseline social isolation showed significantly accelerated increases in depressive symptoms over time, with the interaction between time and high isolation yielding a coefficient of 0.21 on the CES-D-10 scale, statistically significant at p less than 0.001. In plain terms, isolated individuals did not merely start with more depressive symptoms; their symptoms climbed faster year after year compared with socially connected peers. The same pattern held for cognition: higher baseline isolation predicted faster cognitive decline across the seven follow-up waves. This suggests that social disconnection is not a static risk factor whose harm is front-loaded at baseline but a progressive one, compounding its effects on both mood and the brain as the years accumulate.

Perhaps the most consequential findings came from the survival analysis. Among 2,211 participants who were free of depression at baseline, the researchers used Cox proportional hazards models to ask who would develop depression over the following seven years. Both dimensions of disconnection independently predicted incident depression, but loneliness carried the heavier load: self-perceived loneliness was associated with an adjusted hazard ratio of 2.15, with a 95 percent confidence interval of 1.80 to 2.56, meaning lonely individuals were more than twice as likely to become depressed as those who did not feel lonely. High social isolation independently raised risk as well, with an adjusted hazard ratio of 1.89 (95 percent CI: 1.52 to 2.35). Critically, when the two conditions co-occurred, risk multiplied rather than merely added: participants who were both isolated and lonely faced an adjusted hazard ratio of 3.05 (95 percent CI: 2.48 to 3.75), nearly triple the hazard of their connected and contented counterparts.

That multiplicative pattern carries real biological and clinical weight. It implies that the objective absence of social contact and the subjective feeling of loneliness likely operate through partially distinct pathways—perhaps through different combinations of chronic stress physiology, inflammation, reduced cognitive reserve, behavioral changes such as physical inactivity and poor sleep, and the loss of the buffering effects that social support exerts on life stressors. When both pathways are active simultaneously, the brain appears to face a converging set of pressures that neither dimension alone fully captures. For clinicians and public health planners, the message is that screening for either isolation or loneliness alone would miss a substantial share of the people at highest risk; the two must be assessed together.

The study’s second methodological innovation pushes it into the emerging frontier of machine learning in psychiatric epidemiology. The researchers built a logistic regression model trained to predict seven-year incident depression, then applied SHAP—Shapley Additive Explanations, a technique borrowed from game theory that quantifies each feature’s contribution to a model’s predictions—to rank the predictors. The model achieved an area under the receiver operating characteristic curve of 0.821, a level of discrimination that the authors describe as strong for a long-horizon prediction task. What made headlines, however, was the ranking itself: SHAP analysis identified loneliness as the single foremost predictor of future depression, surpassing not only baseline depressive symptoms and functional impairment but also conventional biomarkers. In other words, a simple self-reported feeling outperformed clinical measures that clinicians routinely treat as gold-standard risk indicators.

This finding challenges an implicit hierarchy in geriatric mental health care. Baseline depressive symptoms are often assumed to be the dominant predictor of future depression, and objective health markers—chronic disease burden, disability, laboratory values—are treated as the essential context. The CHARLS-based analysis suggests that how connected older adults feel may deserve equal or greater attention at the point of screening. Because loneliness is inexpensive to measure with a few validated questions, integrating it into routine primary care assessments, community health surveys, and national aging studies could be one of the most cost-effective interventions available for identifying people who will develop depression years before they reach a diagnostic threshold.

The implications extend to intervention design as well. If loneliness is the stronger and more progressive risk factor, then simply increasing the number of social contacts—arranging visits, expanding networks, encouraging group activities—may not be sufficient for people whose isolation is subjective rather than objective. Effective interventions may need to address the quality and meaning of social relationships, targeting the perceived gap between desired and actual connection. Conversely, for people who are objectively isolated but not lonely, the urgency may be lower than traditional risk models would suggest. The co-occurrence finding points to a practical triage strategy: older adults who are both isolated and lonely represent a small but extremely high-risk group—nearly triple the hazard of incident depression—who could be prioritized for intensive, multi-component support.

The study, published open access under a Creative Commons license and funded by a series of Zhejiang provincial health and science programs, is not without limitations inherent to observational cohort research. Association does not prove causation, and reverse causality remains possible: subclinical depression may itself erode social ties and amplify feelings of loneliness before it manifests as measurable symptoms. Residual confounding by personality traits, socioeconomic conditions, and unmeasured health factors cannot be excluded. Yet the seven-year prospective design, the large sample, the separation of objective and subjective disconnection, and the convergence of trajectory modeling, survival analysis, and machine learning explanation give the findings unusual robustness. As populations across China and the world age rapidly, the work adds to a growing body of evidence that social connection is not a soft variable in healthy aging but a core determinant of mental and cognitive health—one that clinicians, policymakers, and families ignore at substantial cost. The authors’ conclusion is unambiguous: social disconnectedness, and loneliness in particular, should be treated as a key, measurable, and modifiable target for screening and intervention in aging adults.

Subject of Research: Longitudinal associations of social isolation and loneliness with depression and cognitive decline in aging adults

Article Title: Social isolation, self-perceived loneliness, and the 7-year trajectories of depression and cognitive decline: a prospective cohort study

Article References: Shen, Y., & Shen, Y. (2026). Social isolation, self-perceived loneliness, and the 7-year trajectories of depression and cognitive decline: a prospective cohort study. BMC Public Health. https://doi.org/10.1186/s12889-026-29637-7

Image Credits: AI Generated

DOI: 10.1186/s12889-026-29637-7

Keywords: loneliness, social isolation, depression, cognitive decline, aging, CHARLS, prospective cohort, machine learning, SHAP, mental health, public health, CES-D-10

The research team, led by Mixue Guo of Northwest Minzu University in Lanzhou together with colleagues across several Chinese institutions and Erasmus MC in the Netherlands, drew on the China Health and Retirement Longitudinal Study, one of the most comprehensive aging surveys in the developing world. Known as CHARLS, the survey follows a nationally representative sample of Chinese residents aged 45 and above, collecting detailed information on health, economics, and household conditions. For this analysis, the investigators focused on participants who were free of depressive symptoms in 2013 and tracked them through 2020, creating a seven-year window in which new cases of depression could emerge and be linked back to baseline environmental conditions.

The central innovation of the study lies in its exposure measure. Rather than isolating a single hazard—say, air pollution or unsafe water—the researchers constructed a composite index called living environmental quality, or LEQ. This score integrated five domains: the structural adequacy of the home, indoor thermal comfort, the source of drinking water, the fuels used for cooking and heating, and ambient exposure to fine particulate matter known as PM2.5. Higher scores on the index indicated poorer conditions across these domains. The approach reflects a growing recognition in environmental health research that people do not experience risks one at a time; they experience them simultaneously, in the same rooms and neighborhoods, often compounding one another.

Depressive symptoms were assessed using the ten-item Center for Epidemiologic Studies Depression Scale, a widely validated screening instrument abbreviated as CES-D-10. Participants scoring ten or higher on this scale were classified as having clinically relevant depressive symptoms. Among the 2,194 participants who entered the analysis without depressive symptoms at baseline, 698—roughly 31.8 percent—crossed that threshold by 2020. That nearly one in three initially healthy participants developed depressive symptoms over the follow-up period underscores the scale of the mental health challenge facing China’s rapidly aging society.

The statistical architecture of the study was deliberately cautious. The researchers used logistic regression models and adjusted sequentially for blocks of potential confounders: demographic characteristics first, then socioeconomic factors including education and household wage and bonus income, then lifestyle variables, and finally clinical factors. Only after this full adjustment did they estimate the association between baseline LEQ and later depression. The result held: each one-point increase in the LEQ score, indicating worse environmental conditions, was associated with a 9.6 percent increase in the odds of developing depressive symptoms, with an odds ratio of 1.096 and a 95 percent confidence interval running from 1.010 to 1.190.

The contrast between environmental extremes was even more striking. When participants were divided into tertiles based on their LEQ scores, those in the highest tertile—meaning those living in the poorest conditions—had 32.7 percent higher odds of incident depressive symptoms compared with those in the lowest tertile, with an odds ratio of 1.327 and a confidence interval of 1.033 to 1.706. Restricted cubic spline analysis, a flexible statistical technique for mapping the shape of a dose-response relationship, revealed an approximately increasing pattern: as living environmental quality worsened, depression risk climbed. Formal statistical tests did not detect evidence of nonlinearity, suggesting the relationship behaves roughly like a straight line across the observed range rather than rising sharply only at some threshold of deprivation.

Equally important is what the researchers did not find. Subgroup analyses, which tested whether the association differed by factors such as sex, age, residence, or socioeconomic status, showed broadly consistent results across the board, with no statistically significant interactions. In other words, the environmental signal did not appear to be confined to a vulnerable slice of the population; it manifested across demographic and economic strata. This consistency strengthens the plausibility of a genuine environmental effect, though the authors and outside observers alike would caution that observational data of this kind cannot definitively prove causation.

Several biological and psychosocial mechanisms could plausibly connect poor living environments to depression. Chronic exposure to indoor air pollution from solid cooking and heating fuels is known to drive systemic inflammation, and inflammatory pathways have been repeatedly implicated in the pathophysiology of depression. Inadequate thermal comfort and poor housing structure can disrupt sleep, and sleep disturbance is one of the most robust prodromal markers of depressive illness. Contaminated drinking water and ambient PM2.5 exposure carry their own burdens of physiological stress. Beyond biology, there is the psychological weight of enduring substandard conditions: the daily friction of a cold, damp, noisy, or unsafe home can erode sense of control, social confidence, and the willingness to invite others in, all of which feed into the social isolation that so often precedes late-life depression.

The study’s strengths are considerable. Its longitudinal design, in which environmental exposure was measured before depressive symptoms appeared, avoids the reverse-causation trap that afflicts cross-sectional research, in which depressed individuals might simply report their surroundings more negatively. The national representativeness of CHARLS, the multi-domain exposure index, and the layered statistical adjustment all lend credibility to the findings. Yet limitations remain. The LEQ score was measured only at baseline and may not capture changes in housing or neighborhood conditions over seven years. The CES-D-10 is a screening tool rather than a clinical diagnostic instrument, so the outcome reflects symptomatic distress rather than formally diagnosed major depression. Residual confounding by unmeasured factors—personality, social support, prior mental health history—cannot be excluded, and the modest magnitude of the per-point effect, while statistically robust, invites careful interpretation.

Even with those caveats, the implications are hard to ignore. China’s population is aging at a pace without historical precedent, and hundreds of millions of older adults still live in homes heated by solid fuels, supplied by unsafe water, or situated in regions with hazardous air quality. If the environment people inhabit contributes measurably to their mental health trajectory, then housing improvement, clean fuel transitions, water safety programs, and air pollution control are not merely public health measures in the conventional sense—they become mental health interventions. The study, published open access with the DOI 10.1186/s12991-026-00698-7, adds its voice to a growing body of evidence that the fight against depression in aging societies may need to begin not in the clinic, but at the kitchen stove, the water tap, and the window that lets in the smog.

Subject of Research: The association between multidomain living environmental quality and incident depressive symptoms among middle-aged and older adults in China

Article Title: Living environmental quality and incident depressive symptoms among middle-aged and older adults in China: a national longitudinal study

Article References: Guo, M., Cai, M., Zhao, Z., Wang, Y., Dong, H., Wei, L., & Xu, K. (2026). Living environmental quality and incident depressive symptoms among middle-aged and older adults in China: a national longitudinal study. Annals of General Psychiatry. https://doi.org/10.1186/s12991-026-00698-7

Image Credits: AI Generated

DOI: 10.1186/s12991-026-00698-7

Keywords: living environmental quality, depressive symptoms, CHARLS, cohort study, older adults, China, housing conditions, air pollution, PM2.5, mental health, CES-D-10, public health